# 1Gene

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/1gene

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Website: www.1gene.com.cn
- Total disclosed funding: $0.8M
- Latest round: Seed (Sep 5, 2014)
- Investors on record: 1

## About

Established in 2014 and based in Hangzhou, China, 1Gene operates as a genetic testing institute that provides cancer early screening products and has partnerships with aliyun.com, Zhejiang Cancer Hospital, Illumina, etc. It qualified as a medical laboratory in January 2017. In April 2022, it passed the KRAS mutation interval quality assessment with a full score.

The company's products can be categorized into bowel cancer early screening, stomach cancer early screening, gastrointestinal cancer early screening, fecal occult blood self-test, full set of tumor genetic susceptibility tests, and gastric cancer pathogenic bacteria screening and medication guidance.

## Funding rounds

- Seed, Sep 5, 2014, $0.8M — TiSiWi

## Investors

- TiSiWi (https://capitalatlas.ai/funds/tisiwi) — Seed